Table of Contents
Advertisement
The following drug parameters are only configurable via the Alaris® PK Editor Software (PC based), and are referenced when the Alaris® PK
Syringe Pump is being used with a drug name selected. Refer to the Alaris® PK Editor Software Directions for Use (1000CH00016) for details
on how to configure the Profile Drug Library.
TCI - these options are only displayed if the selected drug has an associated TCI model.
Clinical Trial Indicator
TIVA Predictive Mode Only
Default Target Concentration
Enable Effect Site Targeting
Enable Target Swapping
Enable TIVA/ TCI Switching
Target Soft Alert Max
Default Decrement Concentration
TIVA Induction Parameters
Induction ON/OFF
Dosing Units
Default Dose
Default Induction Time
Soft Alert Min
Soft Alert Max
Hard Limit Max
Pause After Induction
TIVA Maintenance Parameters
Dose Rate Units
Default Dose Rate
Soft Alert Min
Soft Alert Max
Hard Alert Max
TIVA Bolus Parameters
Bolus Type
Default Rate
Dosing Units
Default Dose (HANDS FREE only)
Soft Alert Min (HANDS FREE only)
Soft Alert Max (HANDS FREE only)
Hard Limit Max (HANDS FREE only)
Occlusion Alarms
Occlusion Alarm Pressure
Desensitise Threshold Rate
Concentration Limits
Minimum Concentration
Maximum Concentration
Configured Options (continued)
Alaris® PK Editor Software - Profile Drugs
Should be set to cause the Alaris® PK Syringe Pump to identify that a selected drug/model
is used under the responsibility of the investigator of a clinical trial protocol. Specifically for
publication studies and when drug does not make reference to the selected TCI mode of
administration in the prescribing information or, when parameter selection deviates from it.
Only allows drugs with associated TCI model to be used in TIVA predictive mode.
The default target concentration offered when the drug is selected.
Enable effect site targeting if the model associated with the drug supports it.
Enable switching between plasma and effect site targeting if the model associated with the
drug supports both modes.
Enable switching between TIVA and TCI modes.
Sets the target concentration soft alert maximum.
Sets the default decrement target concentration.
Enables/Disables induction stage of TIVA protocol.
The induction dose units. This can be based on patient weight.
The default induction dose offered.
Sets the default induction time.
The induction value below which an override confirmation is required.
The induction value above which an override confirmation is required.
The maximum allowed induction dose.
Enables/Disables pause after induction.
The maintenance rate units.
The default maintenance dose.
The maintenance dose rate below which an override confirmation is required.
The maintenance dose rate above which an override confirmation is required.
The maximum allowed maintenance dose rate.
Determines bolus operation when required.
The default bolus rate.
The bolus dose units. This can be based on patient weight.
The default bolus offered.
The bolus dose value below which an override confirmation is required.
The bolus dose value above which an override confirmation is required.
The maximum allowed bolus dose.
The default occlusion alarm level.
The infusion rate that, when exceeded in TCI mode, causes the occlusion detection to be
desensitised.
The minimum drug concentration.
The maximum drug concentration.
1000DF00005 Iss. 2
27/44
Advertisement
Table of Contents
